Literature DB >> 12102637

Kinetic mechanism for human Rho-Kinase II (ROCK-II).

John W Trauger1, Fen-Fen Lin, Mary S Turner, Jeffrey Stephens, Philip V LoGrasso.   

Abstract

Rho-Kinase is a serine/threonine kinase that is involved in the regulation of smooth muscle contraction and cytoskeletal reorganization of nonmuscle cells. While the signal transduction pathway in which Rho-Kinase participates has been and continues to be extensively studied, the kinetic mechanism of Rho-Kinase-catalyzed phosphorylation has not been investigated. We report here elucidation of the kinetic mechanism for Rho-Kinase by using steady-state kinetic studies. These studies used the kinase domain of human Rho-Kinase II (ROCK-II 1-534) with S6 peptide (biotin-AKRRRLSSLRA-NH(2)) as the phosphorylatable substrate. Double-reciprocal plots for two-substrate kinetic data yielded intersecting line patterns with either ATP or S6 peptide as the varied substrate, indicating that Rho-Kinase utilized a ternary complex (sequential) kinetic mechanism. Dead-end inhibition studies were used to investigate the order of binding for ATP and the peptide substrate. The ATP-competitive inhibitors AMP-PCP and Y-27632 were noncompetitive inhibitors versus S6 peptide, and the S6 peptide analogue S6-AA (acetyl-AKRRRLAALRA-NH(2)) was a competitive inhibitor versus S6 peptide and a noncompetitive inhibitor versus ATP. These results indicated a random order of binding for ATP and S6 peptide.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12102637     DOI: 10.1021/bi0258243

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  5 in total

1.  New insights into the structure-function relationships of Rho-associated kinase: a thermodynamic and hydrodynamic study of the dimer-to-monomer transition and its kinetic implications.

Authors:  John D Doran; Xun Liu; Paul Taslimi; Ahmad Saadat; Ted Fox
Journal:  Biochem J       Date:  2004-12-01       Impact factor: 3.857

2.  Steady-state kinetic mechanism of PDK1.

Authors:  Xinxin Gao; Thomas K Harris
Journal:  J Biol Chem       Date:  2006-05-31       Impact factor: 5.157

3.  Enzyme kinetics and distinct modulation of the protein kinase N family of kinases by lipid activators and small molecule inhibitors.

Authors:  Matthew D Falk; Wei Liu; Ben Bolaños; Keziban Unsal-Kacmaz; Anke Klippel; Stephan Grant; Alexei Brooun; Sergei Timofeevski
Journal:  Biosci Rep       Date:  2014-04-01       Impact factor: 3.840

4.  A proteomic approach for comprehensively screening substrates of protein kinases such as Rho-kinase.

Authors:  Mutsuki Amano; Yuta Tsumura; Kentaro Taki; Hidenori Harada; Kazutaka Mori; Tomoki Nishioka; Katsuhiro Kato; Takeshi Suzuki; Yosuke Nishioka; Akihiro Iwamatsu; Kozo Kaibuchi
Journal:  PLoS One       Date:  2010-01-14       Impact factor: 3.240

5.  mi-R4435-2HG promotes proliferation and inhibits apoptosis of cancer cells in ovarian carcinoma by upregulating ROCK2.

Authors:  Jinghui Hu; Li Wang; Wei Zhao; Yujie Huang; Zhe Wang; Heping Shen
Journal:  Oncol Lett       Date:  2019-12-11       Impact factor: 2.967

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.